Tenet Healthcare (NYSE:THC) is a prominent player in the healthcare sector, providing a wide range of services through its network of hospitals and outpatient centers. The company competes with other healthcare providers like Universal Health Services and Lifestance Health Group. Recently, Tenet has been in the spotlight due to a revised price target set by Goldman Sachs.
On December 16, 2024, Jamie Perse from Goldman Sachs set a price target of $140 for Tenet Healthcare. At that time, the stock was trading at $139.10, showing a slight difference of about 0.65% from the target. This adjustment reflects a cautious approach due to increasing policy uncertainty affecting healthcare providers.
Goldman Sachs downgraded Tenet from a Buy to a Neutral rating, reducing the price target from $196 to $140. This change is due to policy risks that could impact Tenet's stock valuation. The analyst suggests that these risks might keep Tenet's shares within a limited range until there's more clarity on policy outcomes.
Currently, Tenet's stock price is $136.71, marking an increase of 0.9973% or $1.35. The stock has traded between $135.62 and $137.73 today. Over the past year, Tenet's stock has seen a high of $171.2 and a low of $73.21, indicating significant volatility.
Tenet's market capitalization is approximately $13 billion, reflecting its substantial presence in the healthcare industry. Today's trading volume on the NYSE is 763,232 shares, showing active investor interest. Despite the downgrade, Tenet remains a key player in the sector, navigating through policy challenges.
Symbol | Price | %chg |
---|---|---|
SILO.JK | 3110 | -0.32 |
MIKA.JK | 2370 | -0.42 |
SRAJ.JK | 2350 | -0.43 |
HEAL.JK | 1570 | -0.32 |